Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 20 of 31
EMA-Defined Tinnitus Subgroups
NCT02191592
Clinical Study of Generic and Brand Bupropion in Depression
NCT02209597
PD 0332991 and Cetuximab in Patients With Incurable SCCHN
NCT02101034
Reduction of Excessive Calories From Beverages in Children
NCT02239653
Short Term Intermittent Fasting and Mediterranean Diet
NCT02148458
Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT02117115
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery
NCT02112162
Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial
NCT02137200
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer
NCT02172846
Omega-3 for Depression and Other Cardiac Risk Factors - 2
NCT02021669
Assessing NOS Uptake With PET Imaging in Lung Inflammation
NCT02151552
Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation
NCT01964222
Effect of Skipping Breakfast on Metabolic Function
NCT02093572
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
NCT02167217
Tumor: Breast Ratio Study
NCT02216136
Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer
NCT02076074
Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma
NCT01969435
Tranexamic Acid Dosing in Adult Spinal Deformity Surgery
NCT02053363
Autologous Fecal Therapy
NCT02046525
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome
NCT02122666
Diabetes and Glycosylation in Cervical Spondylosis
NCT02758899
Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT02057770
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
NCT01986829
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
NCT01690988
Immune Characterization of Subcutaneous Adipose Tissue
NCT02076087
Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
NCT02316795
89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
NCT02065609
Calorie Restriction in Multiple Sclerosis Patients
NCT02411838
PET Assessment of Acute Lung Transplant Rejection
NCT02204202
Bone Marrow Aspirate Concentration in Posterior Cervical Fusion
NCT02068547
Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries
NCT02102386
Spinal Control During Functional Activities to Improve Low Back Pain Outcomes
NCT02027623
A Randomized Controlled Trial of PCIT-ED for Preschool Depression
NCT02076425
Medication Enhanced Rapid Therapy
NCT02099825
Assessing Change in Patient-reported Quality of Life After Elective Surgery: an Observational Comparison Study
NCT02771964
Age of Blood in Children in Pediatric Intensive Care Units
NCT01977547
Probiotics to Promote Intestinal Health
NCT02046512
Proton Beam Therapy to Treat Esophageal Cancer
NCT02023541
Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy In The Evaluation Of Obscure Gastrointestinal Bleeding: A Randomized Controlled Trial
NCT02315404
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
NCT01779050
Registry for Proton Beam Radiation Therapy
NCT02040467
Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
NCT02063217
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
NCT02021682
Protein Intake & Insulin Action
NCT02004002
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
NCT01913951
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
NCT01928290
CYP2B6 Polymorphisms in Ketamine
NCT01988922
Diagnosis of Bile Duct Strictures
NCT02000999
Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
NCT01907165
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.